Funding Rounds
Immunocore Series C (2021, $75M)
ImmunocoreImmunocore Limited is a biotechnology research company based in Abingdon, Oxfordshire focused on developing therapies for the treatment of cancer.
Summary
Stage: Series C
Raised Amount: $75.00M
Raised Date: 2021-01-01